Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Autologous mononuclear cells derived from human cord blood

EU orphan designation number: EU/3/16/1744   
Active ingredient: Autologous mononuclear cells derived from human cord blood
Indication: Treatment of periventricular leukomalacia
Sponsor: BrainRepair UG (haftungsbeschränkt)
Universitätsstraße 140, 44799 Bochum, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/099/16 (2016)6735 of 14/10/2016